A blinded cross-over study of the effects of high dose simvastatin vs. atorvastatin on lipoprotein profiles, apolipoprotein B, apolipoprotein A1 and high sensitivity C-reactive protein.

Trial Profile

A blinded cross-over study of the effects of high dose simvastatin vs. atorvastatin on lipoprotein profiles, apolipoprotein B, apolipoprotein A1 and high sensitivity C-reactive protein.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Atorvastatin; Simvastatin
  • Indications Low HDL cholesterol
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2011 Planned End Date changed from 1 Jun 2012 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 29 Apr 2011 Planned End Date changed from 1 Jan 2010 to 1 Jun 2012, according to the Oregon Health and Science University Institutional Review Board.
    • 14 Jan 2010 New source identified and integrated (Oregon Health and Science University Institutional Review Board).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top